Smoking and schizophrenia: abnormal nicotinic receptor expression

Author： Leonard S.   Breese C.   Adams C.   Benhammou K.   Gault J.   Stevens K.   Lee M.   Adler L.   Olincy A.   Ross R.   Freedman R.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.393, Iss.1, 2000-03, pp. : 237-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are Differential Behavioral Responses to Smoking and Smoking Cessation in Schizophrenia Related to Nicotinic Receptor Levels?

By Leonard S.   Giordano L.  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 1082-1083

Elsevier

Access to resources Recommend Favorite

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

By Tutka Piotr  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1473-1485

Informa Healthcare

Access to resources Recommend Favorite

7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 171-184

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

By Martin Laura   Kem William   Freedman Robert  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 54-64

Springer Publishing Company

Access to resources Recommend Favorite

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

By Geerts Hugo  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 59-65

Informa Healthcare

Access to resources Recommend Favorite